{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:03:56Z","timestamp":1787688236840,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s10654-009-9330-2","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T11:35:17Z","timestamp":1237980917000},"page":"267-274","source":"Crossref","is-referenced-by-count":10,"title":["Adherence to the Mediterranean diet is associated with a lower risk of body-shape changes in Croatian patients treated with combination antiretroviral therapy"],"prefix":"10.1007","volume":"24","author":[{"given":"Drago","family":"Tur\u010dinov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Begovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,26]]},"reference":[{"key":"9330_CR1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51\u20138.","journal-title":"AIDS"},{"key":"9330_CR2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","volume":"31","author":"R Thiebaut","year":"2000","unstructured":"Thiebaut R, Daucourt V, Mercie P, et al. Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d\u2019Epidemiologie Clinique du Syndrome d\u2019Immunodeficience Acquise en Aquitaine. Clin Infect Dis. 2000;31:1482\u20137.","journal-title":"Clin Infect Dis"},{"key":"9330_CR3","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","volume":"87","author":"D Chen","year":"2002","unstructured":"Chen D, Misra A, Garg A. Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab. 2002;87:4845\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"9330_CR4","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","volume":"40","author":"DL Jacobson","year":"2005","unstructured":"Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis. 2005;40:1837\u201345.","journal-title":"Clin Infect Dis"},{"key":"9330_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","volume":"351","author":"KD Miller","year":"1998","unstructured":"Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet. 1998;351:871\u20135.","journal-title":"Lancet"},{"key":"9330_CR6","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14:F25\u201332.","journal-title":"AIDS"},{"key":"9330_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","volume":"40","author":"P Bacchetti","year":"2005","unstructured":"Bacchetti P, Gripshover B, Grunfeld C, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr. 2005;40:121\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.qai.0000214811.72916.67","volume":"41","author":"K Mulligan","year":"2006","unstructured":"Mulligan K, Parker RA, Komarow L, et al. Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. J Acquir Immune Defic Syndr. 2006;41:590\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.qai.0000229996.75116.da","volume":"42","author":"Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM)","year":"2006","unstructured":"Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr 2006;42:562\u201371.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00002030-200008180-00020","volume":"14","author":"MJ Batterham","year":"2000","unstructured":"Batterham MJ, Garsia R, Greenop PA. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy \u2018Diet FRS Study\u2019. AIDS. 2000;14:1839\u201343.","journal-title":"AIDS"},{"key":"9330_CR11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/322680","volume":"33","author":"C Hadigan","year":"2001","unstructured":"Hadigan C, Jeste S, Anderson EJ, Tsay R, Cyr H, Grinspoon S. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. Clin Infect Dis. 2001;33:710\u20137.","journal-title":"Clin Infect Dis"},{"key":"9330_CR12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00002030-200210180-00014","volume":"16","author":"A Barrios","year":"2002","unstructured":"Barrios A, Blanco F, Garcia-Benayas T, et al. Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia. AIDS. 2002;16:2079\u201381.","journal-title":"AIDS"},{"key":"9330_CR13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/338402","volume":"34","author":"R Roubenoff","year":"2002","unstructured":"Roubenoff R, Schmitz H, Bairos L, et al. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle. Clin Infect Dis. 2002;34:390\u20133.","journal-title":"Clin Infect Dis"},{"key":"9330_CR14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/ajcn\/78.4.790","volume":"78","author":"KM Hendricks","year":"2003","unstructured":"Hendricks KM, Dong KR, Tang AM, et al. High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition. Am J Clin Nutr. 2003;78:790\u20135.","journal-title":"Am J Clin Nutr"},{"key":"9330_CR15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1079\/PHN2004558","volume":"7","author":"A Trichopoulou","year":"2004","unstructured":"Trichopoulou A. Traditional Mediterranean diet and longevity in the elderly: a review. Public Health Nutr. 2004;7:943\u20137.","journal-title":"Public Health Nutr"},{"key":"9330_CR16","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa025039","volume":"348","author":"A Trichopoulou","year":"2003","unstructured":"Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599\u2013608.","journal-title":"N Engl J Med"},{"key":"9330_CR17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.38415.644155.8F","volume":"330","author":"A Trichopoulou","year":"2005","unstructured":"Trichopoulou A, Orfanos P, Norat T, et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ. 2005;330:991.","journal-title":"BMJ"},{"key":"9330_CR18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1079\/BJN20061824","volume":"96","author":"P Lagiou","year":"2006","unstructured":"Lagiou P, Trichopoulos D, Sandin S, et al. Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr. 2006;96:384\u201392.","journal-title":"Br J Nutr"},{"key":"9330_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-145-1-200607040-00004","volume":"145","author":"R Estruch","year":"2006","unstructured":"Estruch R, Martinez-Gonzalez MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145:1\u201311.","journal-title":"Ann Intern Med"},{"key":"9330_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/B:EJEP.0000013351.60227.7b","volume":"19","author":"MA Martinez-Gonzalez","year":"2004","unstructured":"Martinez-Gonzalez MA, Sanchez-Villegas A. The emerging role of Mediterranean diets in cardiovascular epidemiology: monounsaturated fats, olive oil, red wine or the whole pattern? Eur J Epidemiol. 2004;19:9\u201313.","journal-title":"Eur J Epidemiol"},{"key":"9330_CR21","first-page":"7","volume":"19","author":"D Trichopoulos","year":"2004","unstructured":"Trichopoulos D, Lagiou P. Mediterranean diet and cardiovascular epidemiology. Eur J Epidemiol. 2004;19:7\u20138.","journal-title":"Eur J Epidemiol"},{"key":"9330_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008469-200502000-00004","volume":"14","author":"V Cottet","year":"2005","unstructured":"Cottet V, Bonithon-Kopp C, Kronborg O, et al. Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev. 2005;14:21\u20139.","journal-title":"Eur J Cancer Prev"},{"key":"9330_CR23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1079\/PHN2004562","volume":"7","author":"C La Vecchia","year":"2004","unstructured":"La Vecchia C. Mediterranean diet and cancer. Public Health Nutr. 2004;7:965\u20138.","journal-title":"Public Health Nutr"},{"key":"9330_CR24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"9330_CR25","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498\u2013504.","journal-title":"Med Sci Sports Exerc"},{"key":"9330_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15:1389\u201398.","journal-title":"AIDS"},{"key":"9330_CR27","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","volume":"332","author":"L Hooper","year":"2006","unstructured":"Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752\u201360.","journal-title":"BMJ"},{"issue":"Suppl 2","key":"9330_CR28","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1086\/375883","volume":"37","author":"JE Forrester","year":"2003","unstructured":"Forrester JE, Gorbach SL. Fat distribution in relation to drug use, human immunodeficiency virus (HIV) status, and the use of antiretroviral therapies in Hispanic patients with HIV infection. Clin Infect Dis. 2003;37(Suppl 2):S62\u20138.","journal-title":"Clin Infect Dis"},{"key":"9330_CR29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","volume":"357","author":"E Martinez","year":"2001","unstructured":"Martinez E, Mocroft A, Garcia-Viejo MA, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet. 2001;357:592\u20138.","journal-title":"Lancet"},{"key":"9330_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","volume":"4","author":"J Miller","year":"2003","unstructured":"Miller J, Carr A, Emery S, et al. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med. 2003;4:293\u2013301.","journal-title":"HIV Med"},{"key":"9330_CR31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","volume":"30","author":"KV Heath","year":"2002","unstructured":"Heath KV, Hogg RS, Singer J, Chan KJ, O\u2019Shaughnessy MV, Montaner JS. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort. J Acquir Immune Defic Syndr. 2002;30:440\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR32","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","volume":"34","author":"M Saves","year":"2002","unstructured":"Saves M, Raffi F, Capeau J, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002;34:1396\u2013405.","journal-title":"Clin Infect Dis"},{"key":"9330_CR33","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","volume":"16","author":"V Joly","year":"2002","unstructured":"Joly V, Flandre P, Meiffredy V, et al. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS. 2002;16:2447\u201354.","journal-title":"AIDS"},{"key":"9330_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200107010-00004","volume":"27","author":"JR Bogner","year":"2001","unstructured":"Bogner JR, Vielhauer V, Beckmann RA, et al. Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr. 2001;27:237\u201344.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR35","first-page":"73","volume":"10","author":"J Young","year":"2005","unstructured":"Young J, Rickenbach M, Weber R, et al. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Antivir Ther. 2005;10:73\u201381.","journal-title":"Antivir Ther"},{"key":"9330_CR36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00126334-200301010-00007","volume":"32","author":"KA Lichtenstein","year":"2003","unstructured":"Lichtenstein KA, Delaney KM, Armon C, et al. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr. 2003;32:48\u201356.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9330_CR37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191\u2013201.","journal-title":"JAMA"},{"key":"9330_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","volume":"354","author":"JE Gallant","year":"2006","unstructured":"Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006;354:251\u201360.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-009-9330-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T16:33:39Z","timestamp":1554914019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-009-9330-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,26]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["9330"],"URL":"https:\/\/doi.org\/10.1007\/s10654-009-9330-2","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,26]]}}}